Literature DB >> 16126184

Genetic testing for pharmacogenetics and its clinical application in drug therapy.

Masahiro Hiratsuka1, Takamitsu Sasaki, Michinao Mizugaki.   

Abstract

There is wide individual variation in drug responses and adverse effects. As the main causes of the variation in drug responses, attention has focused on the genetic polymorphisms that encode metabolic enzymes regulating pharmacodynamics and receptors modulating the affinity with the responsive sites. Tailor-made drug therapy analyzes genetic polymorphisms involved in drug responses before drug administration and selects drugs and doses suitable for the individual genetic background. Establishment of tailor-made drug therapy is expected to contribute to medical economy by avoiding wasteful drug administration. To promote such medical practice, it is necessary to use simple genetic testing that is clinically convenient. Currently, genetic testing using real-time PCR has been frequently employed at laboratories with its clinical application anticipated. As to the many genes involved in drug responses, to date, the application of patient genetic information to tailor-made drug therapy has been achieved at the practical level. Information on pharmacogenetics will be a critical factor in medical practice in the near future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126184     DOI: 10.1016/j.cccn.2005.05.047

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

Review 1.  Brain plasticity and genetic factors.

Authors:  Kristin M Pearson-Fuhrhop; Jeffrey A Kleim; Steven C Cramer
Journal:  Top Stroke Rehabil       Date:  2009 Jul-Aug       Impact factor: 2.119

2.  Single-channel multiplexing without melting curve analysis in real-time PCR.

Authors:  Young-Jo Lee; Daeyoung Kim; Kihoon Lee; Jong-Yoon Chun
Journal:  Sci Rep       Date:  2014-12-11       Impact factor: 4.379

3.  Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study.

Authors:  Joseph Finkelstein; Carol Friedman; George Hripcsak; Manuel Cabrera
Journal:  Pharmgenomics Pers Med       Date:  2016-10-14

4.  The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications.

Authors:  Teresa McMahon; Joseph Tucci
Journal:  Pharm Pract (Granada)       Date:  2011-09-14

5.  Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians.

Authors:  Tomoko Hasunuma; Masahiro Tohkin; Nahoko Kaniwa; In-Jin Jang; Cui Yimin; Masaru Kaneko; Yoshiro Saito; Masahiro Takeuchi; Hiroshi Watanabe; Yasushi Yamazoe; Yoshiaki Uyama; Shinichi Kawai
Journal:  Br J Clin Pharmacol       Date:  2016-03-14       Impact factor: 4.335

6.  Potential utility of precision medicine for older adults with polypharmacy: a case series study.

Authors:  Joseph Finkelstein; Carol Friedman; George Hripcsak; Manuel Cabrera
Journal:  Pharmgenomics Pers Med       Date:  2016-04-15

7.  A Use Case to Support Precision Medicine for Frequently Hospitalized Older Adults with Polypharmacy.

Authors:  Manuel Cabrera; Joseph Finkelstein
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2016-07-20

8.  Exploring Responsible Neuroimaging Innovation: Visions From a Societal Actor Perspective.

Authors:  Marlous E Arentshorst; Tjard de Cock Buning; Jacqueline E W Broerse
Journal:  Bull Sci Technol Soc       Date:  2017-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.